These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 6692386)
1. Correspondence re: J. M. Yuhas and A. P. Li. Growth fraction as the major determinant of multicellular tumor spheroid growth rates. Cancer Res., 38: 1528-1532, 1978. Curphey TJ Cancer Res; 1984 Feb; 44(2):866-8. PubMed ID: 6692386 [No Abstract] [Full Text] [Related]
2. A possible bias in growth-kinetic estimates of the thickness of the growing layer in multicellular tumor spheroids. Thron CD Cancer Res; 1984 Sep; 44(9):4208-10. PubMed ID: 6744331 [TBL] [Abstract][Full Text] [Related]
3. Growth fraction as the major determinant of multicellular tumor spheroid growth rates. Yuhas JM; Li AP Cancer Res; 1978 Jun; 38(6):1528-32. PubMed ID: 647668 [TBL] [Abstract][Full Text] [Related]
4. Growth of mammalian multicellular tumor spheroids. Conger AD; Ziskin MC Cancer Res; 1983 Feb; 43(2):556-60. PubMed ID: 6848179 [TBL] [Abstract][Full Text] [Related]
5. Correspondence re: J.A. Knol et al., Incorporation of 5-bromo-2-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res., 55: 3687-3691, 1995. Kinsella TJ Cancer Res; 1996 Jun; 56(11):2677-8. PubMed ID: 8653716 [No Abstract] [Full Text] [Related]
6. A multilevel approach to cancer growth modeling. Delsanto PP; Condat CA; Pugno N; Gliozzi AS; Griffa M J Theor Biol; 2008 Jan; 250(1):16-24. PubMed ID: 18028962 [TBL] [Abstract][Full Text] [Related]
7. Kinetic approach and estimation of the parameters of cellular interaction between the immunity system and a tumor. Kuznetsov VA; Zhivoglyadov VP; Stepanova LA Arch Immunol Ther Exp (Warsz); 1993; 41(1):21-31. PubMed ID: 8239905 [TBL] [Abstract][Full Text] [Related]
9. Correspondence re: L. M. Wein et al., validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res., 63: 1317-1324, 2003. Wodarz D Cancer Res; 2003 Dec; 63(23):8554;author reply 8556-7. PubMed ID: 14679025 [No Abstract] [Full Text] [Related]
10. Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma. Levine HA; Pamuk S; Sleeman BD; Nilsen-Hamilton M Bull Math Biol; 2001 Sep; 63(5):801-63. PubMed ID: 11565406 [TBL] [Abstract][Full Text] [Related]
11. Non-linear model of cancer growth and metastasis: a limiting nutrient as a major determinant of tumor shape and diffusion. Pescarmona GP; Scalerandi M; Delsanto PP; Condat CA Med Hypotheses; 1999 Dec; 53(6):497-503. PubMed ID: 10687891 [TBL] [Abstract][Full Text] [Related]
12. Mathematical models of prevascular spheroid development and catastrophe-theoretic description of rapid metastatic growth/tumor remission. Adam JA Invasion Metastasis; 1996; 16(4-5):247-67. PubMed ID: 9311389 [TBL] [Abstract][Full Text] [Related]
13. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995. Ames BN; Gold LS Cancer Res; 1996 Sep; 56(18):4267-9; author reply 4272-4. PubMed ID: 8797604 [No Abstract] [Full Text] [Related]
14. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995. Cohen SM; Ellwein LB Cancer Res; 1996 Sep; 56(18):4269-70; author reply 4272-3. PubMed ID: 8797605 [No Abstract] [Full Text] [Related]
16. Correspondence re: S. E. Blutt, T. C. Polek, L. V. Stewart, M. W. Kattan, and N. L. Weigel, A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res., 60: 779-782, 2000. Schwartz GG; Lokeshwar BL; Burnstein KL Cancer Res; 2001 May; 61(10):4294. PubMed ID: 11358859 [No Abstract] [Full Text] [Related]
17. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995. Stemmermann GN; Noffsinger A; Fenoglio-Preiser CM Cancer Res; 1996 Sep; 56(18):4267; author reply 4272-4. PubMed ID: 8797603 [No Abstract] [Full Text] [Related]
18. Telomerase therapeutics: telomeres recognized as a DNA damage signal: commentary re: K. Kraemer et al., antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res., 9: 3794-3800, 2003. Shay JW Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3521-5. PubMed ID: 14506137 [No Abstract] [Full Text] [Related]
19. Correspondence re: C. G. Ferreira et al., Apoptosis: target of cancer therapy. Clin. Cancer Res., 8: 2024-2034, 2002. de Vries EG; de Hooge MN; Gietema JA; de Jong S Clin Cancer Res; 2003 Feb; 9(2):912; author reply 913. PubMed ID: 12576467 [No Abstract] [Full Text] [Related]
20. Dormancy, regression, and recurrence: towards a unifying theory of tumor growth control. Michelson S; Leith JT J Theor Biol; 1994 Aug; 169(4):327-38. PubMed ID: 7967626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]